ORAMED PHARMACEUTICALS INC. Foreign Income Tax Expense (Benefit), Continuing Operations
ORAMED PHARMACEUTICALS INC. (ORMP) reported Foreign Income Tax Expense (Benefit), Continuing Operations of -$100.00 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2024-03-06.
Discontinued › Expense Statement › Income Tax
us-gaap:ForeignIncomeTaxExpenseBenefitContinuingOperations · last filed 2024-03-06
- ORAMED PHARMACEUTICALS INC. foreign income tax expense (benefit), continuing operations for fiscal 2022 was -$100.00K.
- ORAMED PHARMACEUTICALS INC. foreign income tax expense (benefit), continuing operations for fiscal 2019 was -$300.00K.
- ORAMED PHARMACEUTICALS INC. foreign income tax expense (benefit), continuing operations for fiscal 2017 was $400.00K, a 70.37% decline from fiscal 2016.
- ORAMED PHARMACEUTICALS INC. foreign income tax expense (benefit), continuing operations for fiscal 2016 was $1.35M.
| Period end | Foreign Income Tax Expense (Benefit), Continuing Operations 12 month | Foreign Income Tax Expense (Benefit), Continuing Operations 12 month as first filed | Foreign Income Tax Expense (Benefit), Continuing Operations 125 month | Foreign Income Tax Expense (Benefit), Continuing Operations 137 month |
|---|---|---|---|---|
| 2022-12-31 | -$100.00K 10-K · filed 2024-03-06 | $100.00K 10-K · filed 2023-03-06 | ||
| 2019-08-31 | -$300.00K 10-K · filed 2020-11-24 | $300.00K 10-K · filed 2019-11-27 | ||
| 2017-08-31 | $400.00K 10-K · filed 2019-11-27 | |||
| 2016-08-31 | $1.35M 10-K · filed 2018-11-28 | |||
| 2015-08-31 | -$1.00K 10-K · filed 2017-11-29 | |||
| 2014-08-31 | $4.00K 10-K · filed 2016-11-25 | |||
| 2013-08-31 | -$192.00K 10-K · filed 2015-11-25 | -$192.10K 10-K · filed 2013-11-27 | $108.44K 10-K · filed 2013-11-27 | |
| 2012-08-31 | $98.00K 10-K · filed 2014-11-14 | $97.79K 10-K · filed 2012-12-12 | $202.75K 10-K · filed 2012-12-12 | |
| 2011-08-31 | $9.59K 10-K · filed 2012-12-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |